These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22500250)

  • 1. Socioeconomic costs of overactive bladder and stress urinary incontinence in Korea.
    Sung W; You H; Yoon TY; Lee SJ
    Int Neurourol J; 2012 Mar; 16(1):23-9. PubMed ID: 22500250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database].
    Lim SJ; Kim HJ; Nam CM; Chang HS; Jang YH; Kim S; Kang HY
    J Prev Med Public Health; 2009 Jul; 42(4):251-60. PubMed ID: 19675402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated economic costs of overactive bladder in the United States.
    Hu TW; Wagner TH; Bentkover JD; LeBlanc K; Piancentini A; Stewart WF; Corey R; Zhou SZ; Hunt TL
    Urology; 2003 Jun; 61(6):1123-8. PubMed ID: 12809878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Economic impact of overactive bladder symptoms in Japan].
    Inoue S; Kobayashi M; Sugaya K
    Nihon Hinyokika Gakkai Zasshi; 2008 Nov; 99(7):713-22. PubMed ID: 19068687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the lifetime economic burden of stroke according to the age of onset in South Korea: a cost of illness study.
    Kang HY; Lim SJ; Suh HS; Liew D
    BMC Public Health; 2011 Aug; 11():646. PubMed ID: 21838919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The socioeconomic cost of injuries in South Korea].
    Park K; Lee JS; Kim Y; Kim YI; Kim J
    J Prev Med Public Health; 2009 Jan; 42(1):5-11. PubMed ID: 19229119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder.
    Tang DH; Colayco DC; Khalaf KM; Piercy J; Patel V; Globe D; Ginsberg D
    BJU Int; 2014 Mar; 113(3):484-91. PubMed ID: 24528881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea.
    Kim YK; Song JY; Jang H; Kim TH; Koo H; Varghese L; Han E
    Pharmacoeconomics; 2018 Dec; 36(12):1475-1490. PubMed ID: 30251078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic costs of overactive bladder in Germany.
    Klotz T; Brüggenjürgen B; Burkart M; Resch A
    Eur Urol; 2007 Jun; 51(6):1654-62; discussion 1662-3. PubMed ID: 17161521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic impact of overactive bladder syndrome in six Western countries.
    Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
    BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic considerations in overactive bladder.
    Hu TW; Wagner TH
    Am J Manag Care; 2000 Jul; 6(11 Suppl):S591-8. PubMed ID: 11183902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The total economic burden of overactive bladder in the United States: a disease-specific approach.
    Onukwugha E; Zuckerman IH; McNally D; Coyne KS; Vats V; Mullins CD
    Am J Manag Care; 2009 Mar; 15(4 Suppl):S90-7. PubMed ID: 19355803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global prevalence and economic burden of urgency urinary incontinence: a systematic review.
    Milsom I; Coyne KS; Nicholson S; Kvasz M; Chen CI; Wein AJ
    Eur Urol; 2014 Jan; 65(1):79-95. PubMed ID: 24007713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current and future burden and cost of overactive bladder in five European countries.
    Reeves P; Irwin D; Kelleher C; Milsom I; Kopp Z; Calvert N; Lloyd A
    Eur Urol; 2006 Nov; 50(5):1050-7. PubMed ID: 16753252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of the societal costs of hepatitis B in South Korea.
    Yang BM; Paik SW; Hahn OS; Yi DH; Choi MS; Payne S
    J Gastroenterol Hepatol; 2001 Mar; 16(3):301-8. PubMed ID: 11339422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic burden of overactive bladder in the United States: A systematic literature review.
    Powell LC; Szabo SM; Walker D; Gooch K
    Neurourol Urodyn; 2018 Apr; 37(4):1241-1249. PubMed ID: 29331047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of tension-free vaginal tape on overactive bladder symptoms in women with stress urinary incontinence: significance of detrusor overactivity.
    Choe JH; Choo MS; Lee KS
    J Urol; 2008 Jan; 179(1):214-9. PubMed ID: 18001792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Impact of Atopic Dermatitis in Korean Patients.
    Kim C; Park KY; Ahn S; Kim DH; Li K; Kim DW; Kim MB; Jo SJ; Yim HW; Seo SJ
    Ann Dermatol; 2015 Jun; 27(3):298-305. PubMed ID: 26082587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for stress, urge or mixed urinary incontinence in Italy.
    Parazzini F; Chiaffarino F; Lavezzari M; Giambanco V;
    BJOG; 2003 Oct; 110(10):927-33. PubMed ID: 14550363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.